Abstract:MicroRNAs (miRNAs) are small, non-coding regulatory RNAs that post-transcriptionally regulate gene expression. These conserved molecules are highly expressed in the brain, being essential for neuronal function and survival. miRNA profiles are significantly altered in Alzheimer's disease (AD) patient brains. We have previously shown that tauroursodeoxycholic acid (TUDCA) is a strong neuroprotective agent in several AD experimental models. In addition, bile acids modulate both mRNA and miRNA expression in the rat liver. Nevertheless, the therapeutic role of TUDCA in AD pathology has not yet been ascertained. The present study was designed to identify miRNAs differentially expressed in wild-type and APP/PS1 transgenic mice, as well as elucidate the role of TUDCA in modulating miRNAs potentially associated with AD. We carried out highly sensitive expression profiling of 1140 miRNAs on samples obtained from the hippocampus and frontal cortex of male APP/PS1 transgenic mice and wild-type littermates fed diets containing 0.4 percent TUDCA, or no bile acid, for 6 months. Validation was performed by qRT-PCR. APP/PS1 mice brains showed significant and large fold-change differential expression of 46 miRNAs including miR-295, -302c, -599, and -615, relative to wild-type mice. In addition, significant differences were also detected in 28 miRNAs in the direct comparison of untreated and TUDCA-treated APP/PS1 mice. Finally, in silico analysis identified putative target genes for specific miRNAs deregulated in APP/PS1 mice and modulated by TUDCA. Pathway enrichment within these putative targets revealed that miRNAs found altered in APP/PS1 mice are potentially involved in axon guidance mechanisms, long-term potentiation and/or depression, glutamate metabolism, and apoptosis. Interestingly, amyloid precursor protein (APP) 3'UTR is potentially targeted by miR-295, which expression was significantly decreased in the cortex of APP/PS1 mice. In contrast, miR-599 was upregulated in the brain of APP/PS1 mice and potentially targets the low-density lipoprotein (LDL) receptor-related protein 6 (LRP6) 3'UTR involved in Aβ clearance. Notably, miR-599 expression was decreased by TUDCA. miRNA profiling of APP/PS1 mice provides an appealing approach to address how changes in miRNA profiles translate into biological functions in AD pathological context. Modulation of AD-associated miRNAs by TUDCA may represent a potential therapeutic strategy for prevention and treatment of the disease.

Inhibition of high-fat diet-induced miRNA ameliorates tau toxicity in Drosophila

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila

MicroRNA Expression Analysis of Adult-onset Drosophila Alzheimer’s Disease Model

The Role of Mir-124 in Drosophila Alzheimer&#39;s Disease Model by Targeting Delta in Notch Signaling Pathway

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease

Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APPSwe/PS1dE9 and Wild-Type C57BL/6J Mice

Intrahippocampal Mir-342-3p Inhibition Reduces Β-Amyloid Plaques and Ameliorates Learning and Memory in Alzheimer's Disease.

Nesfatin-1 ameliorates pathological abnormalities in Drosophila hTau model of Alzheimer's disease

TTC7 and Hyccin Regulate Neuronal Aβ42 Accumulation and Its Associated Neural Deficits in Aβ42-Expressing Drosophila

Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer's Disease Model

Effects of Tau on Aβ-induced Synaptic Damage in a Drosophila Model of Alzheimer's Disease.

Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer’s Disease Mice

Biochemical and Behavioral Evaluation of Human MAPT Mutations in Transgenic Drosophila melanogaster

High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern

Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

High fat diet affects the hippocampal expression of miRNAs targeting brain plasticity-related genes

High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model

P3‐046: Understanding Brain Microrna Profiling in the Double Transgenic APP/PS1 Mouse Model of Alzheimer's Disease

MicroRNA‐128 Suppresses Tau Phosphorylation and Reduces Amyloid‐beta Accumulation by Inhibiting the Expression of GSK3β, APPBP2, and Mtor in Alzheimer's Disease